Additional inclusion criteria were treatment with an ACE inhibitor or angiotensin receptor blocker (or if contraindicated, the combination of hydralazine and nitrates) for at least 6 months with no change in doses of these medications for at least 2 months.
![[This page as RDF]](http://data.gesis.org/somesci/static/rdf-icon.gif){kind=icon}